Literature DB >> 2061947

Intracellular gastrin in human gastrointestinal tumor cells.

S A Watson1, L G Durrant, P M Wencyk, A L Watson, D L Morris.   

Abstract

Flow cytometry and immunohistochemical analyses of the human gastric adenocarcinoma cell line MKN45G identified an intracellular peptide recognized by an anti-gastrin-17 (G17) antiserum but not by an anti-cholecystokinin-specific antiserum. Staining was not associated with the parental line MKN45, of which MKN45G is a clonal variant. The MKN45G cell line had elevated in vitro growth in serum-free medium in which the proliferation of MKN45G cells but not MKN45 cells was reduced to 58% of the control value by treatment with a rabbit anti-G17 antiserum. This inhibition of proliferation was reversed by preabsorbing the antiserum with excess G17. Disaggregated primary human gastric and colorectal tumors were screened for gastrin immunoreactivity by flow cytometry, and 6 of 28 colorectal and 8 of 22 gastric tumors had greater than 20% positively staining cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2061947     DOI: 10.1093/jnci/83.12.866

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

1.  Expression of gastrin, gastrin/CCK-B and gastrin/CCK-C receptors in human colorectal carcinomas.

Authors:  A Imdahl; T Mantamadiotis; S Eggstein; E H Farthmann; G S Baldwin
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

2.  Characterization of the influence of anti-hormone and/or anti-growth factor neutralizing antibodies on cell clone architecture and the growth of human neoplastic astrocytic cell lines.

Authors:  I Camby; I Salmon; S Rorive; T Gras; F Darro; A Kruczynski; A Danguy; J L Pasteels; R Kiss
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

3.  EGF receptor activation stimulates endogenous gastrin gene expression in canine G cells and human gastric cell cultures.

Authors:  M G Ford; J D Valle; C J Soroka; J L Merchant
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

4.  A comparison of the therapeutic effectiveness of gastrin neutralisation in two human gastric cancer models: relation to endocrine and autocrine/paracrine gastrin mediated growth.

Authors:  S A Watson; T M Morris; A Varro; D Michaeli; A M Smith
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

5.  Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7.

Authors:  Yinfei Yin; Anna M Grabowska; Philip A Clarke; Elisabeth Whelband; Karen Robinson; Richard H Argent; Amanda Tobias; Rajendra Kumari; John C Atherton; Susan A Watson
Journal:  Gut       Date:  2010-06-28       Impact factor: 23.059

6.  Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidine.

Authors:  S A Watson; L J Wilkinson; J F Robertson; J D Hardcastle
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

7.  Identification of progastrin derived peptides in colorectal carcinoma extracts.

Authors:  J Nemeth; B Taylor; S Pauwels; A Varro; G J Dockray
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

8.  Characterisation of the influence of anti-gastrin, anti-epidermal growth factor, anti-oestradiol, and anti-luteinising hormone releasing hormone antibodies on the proliferation of 27 cell lines from the gastrointestinal tract.

Authors:  F Darro; I Camby; A Kruczynski; J L Pasteels; J Martinez; R Kiss
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

9.  Omeprazole inhibits colorectal carcinogenesis induced by azoxymethane in rats.

Authors:  I D Penman; E el-Omar; J R McGregor; K J Hillan; P J O'Dwyer; K E McColl
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

10.  Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin.

Authors:  M Blackmore; B H Hirst
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.